.A period 3 trial of Daiichi Sankyo and also Merck & Co.'s HER3-directed antibody-drug conjugate ...
.5 months after Rakovina Therapies rotated towards artificial intelligence, the cancer-focused biote...
.Ascendis Pharma has emerged as a possible danger to BioMarin's Voxzogo, reporting phase 3 growth co...
.Though Alkeus Pharmaceuticals' oral eye disease asset failed to substantially minimize geographic d...
.Along with a trio of biotechs attacking the Nasdaq on Friday, it was actually quick and easy to ove...
.Immune checkpoint preventions are actually the superheroes of cancer cells treatment. Medications l...
.Welcome to today's Chutes & Ladders, our summary of considerable leadership hirings, firings and...
.Regeneron is actually back with long-lasting follow-up for its own LAG-3 inhibitor as well as PD-1 ...
.AstraZeneca has actually discussed an early check out the performance of its internal antibody-drug...
.After introducing a phase 3 launch based upon beneficial midstage end results, iTeos as well as GSK...